Term
| What are the MI biochemical markers that fell out of practice and why did they fall out of practice? |
|
Definition
AST: Not specific
LDH: Not Specific
Myoglobin: Not Specific
LDH Isoenzymes(LD1/LD2): Takes too long
|
|
|
Term
| What Biomarkers are currently use to eval MI and when are they used |
|
Definition
CPK: Used to cal CK-MB fraction
CPK-MB: Confirmation in early MI, Reinfarction Assesment
Troponin: Standard to evaluate possible MI |
|
|
Term
| What biochemial marker is being used to evaluate the likelihood of ischemic injury in Unstable Angina? |
|
Definition
|
|
Term
What MI Markers would be increased by:
Exercise/Trauma/Muscle Disease
Renal Disease
Hemorrhagic Stoke |
|
Definition
Exercise: CPK, CPK-MB
Renal: Troponin T
Stroke: CPK-BB |
|
|
Term
| What are the common markers used to evaluate CAD risk in Patients? |
|
Definition
total Cholesterol
Triglycerides, LDL, HDL, Apo(A1), Apo(B), App(A) |
|
|
Term
| Preanalytical problems in measuring lipids |
|
Definition
Position: Standing(Higher) vs Sitting(lower)
Venous Stasis: Increases
Biovariation
Dietary Variation
Medications
|
|
|
Term
| When is the Friedwald Equation invalid |
|
Definition
| Glycerides over 400, Dyslipidproteinemias |
|
|
Term
| What are the CAD equivelents? |
|
Definition
| AAA, PVD, DM, Chronic Kidney, Coratid Artery Disease, >20% on Framingham's |
|
|
Term
| Major Risk factors for CAD |
|
Definition
| Low HDL, Smoking, HPTN, Family History, Age |
|
|
Term
LDL Goals of Treatment For
0-1 Risks
2+ Risks
Equiv |
|
Definition
0-1: <160
2+: <130
Equiv: <100 |
|
|
Term
| What are some diseases that will increase your lipids |
|
Definition
Hypothyroid
DM
Obstructive Liver
Nephrotic Syndrome |
|
|
Term
| What are some new markers for CAD Risk factor |
|
Definition
|
|
